Annotation Detail for NAGA

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa00603 | Glycosphingolipid biosynthesis - globo series |
hsa04142 | Lysosome |
Desease ID | Desease Name |
---|
| Lysosomal storage diseases |
H00146 | Alpha-N-acetylgalactosaminidase deficiency |
| Genetic disorders |
Desease Name |
---|
Schindler disease, type I |
Schindler disease, type III |
Kanzaki disease |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000001 |
Calcimycin |
Calcimycin affects the activity of NAGA protein | affects activity | 18475545
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of NAGA mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of NAGA mRNA | increases expression | 17942748
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NAGA mRNA | affects binding|decreases expression|increases activity | 19710929
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.66 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.58 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.88 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.11 | 16434500 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
4.02 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.89 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.57 | 19483382 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.79 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
15.08 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
15.08 | 16105132 11677210 16919318 17110522 17333356 15861022 17681005 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
15.08 | 19176532 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.57 | 18249437 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.90 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
3.69 | 12538720 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
15.60 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
15.60 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
15.60 | 20131406 19236843 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.70 | 12168785 12639820 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.76 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.55 | 16221962 19772884 18467677 19176532 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.58 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.37 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.92 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.73 | 17937319 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.87 | 16306350 |
MESH:C536891 |
Kanzaki disease |
marker/mechanism |
|
| |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 8314463 18776723 10903974 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.93 | 20007298 15890375 16377806 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
4.07 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.27 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.25 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.11 | 17405874 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 18481113 19348381 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
4.15 | 11578682 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.94 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.55 | 19058328 |
OMIM:609241 |
SCHINDLER DISEASE, TYPE I |
marker/mechanism |
|
| |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.66 | 16709447 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
4.08 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.52 | 15669648 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.80 | 14692618 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.97 | 15869587 14671159 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |
Pathway ID |
Pathway Name |
---|
KEGG:00603 |
Glycosphingolipid biosynthesis - globo series |
KEGG:04142 |
Lysosome |
Drugbank ID |
Action |
Drug Name |
Description |
---|
DB04077 |
- |
Glycerol |
Solvents;Cryoprotective Agents |